Seek approval for regulatory support; FY26 appropriations; education about the microbiome and federal research opportunities. FDA reforms.
2025 · 1st Quarter (Jan 1 - Mar 31)
MICROBIOME THERAPEUTICS INNOVATION GROUP (MTIG)
Filed by THE CONAFAY GROUP, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 18, 2025
- Income
- $10,000.00
- Expenses
- Not reported
- Registrant
- THE CONAFAY GROUP, LLC
- Filing UUID
- bcf8f7b1-9d33-4e77-b3ac-ed7715abb984
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Seek approval for regulatory support; FY26 appropriations; education about the microbiome and federal research opportunities. FDA reforms.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.